Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing.
Pediatric-onset inflammatory bowel disease (IBD) is known to be associated with severe disease, poor response to therapy, and increased morbidity and mortality. We conducted exome sequencing of two brothers from a non-consanguineous relationship who presented before the age of one with severe infantile-onset IBD, failure to thrive, skin rash, and perirectal abscesses refractory to medical management. We examined the variants discovered in all known IBD-associated and primary immunodeficiency genes in both siblings. The siblings were identified to harbor compound heterozygous mutations in IL10RA (c.784C>T, p.Arg262Cys; c.349C>T, p.Arg117Cys). Upon molecular diagnosis, the proband underwent successful hematopoietic stem cell transplantation and demonstrated marked clinical improvement of all IBD-associated clinical symptoms. Exome sequencing can be an effective tool to aid in the molecular diagnosis of pediatric-onset IBD. We provide additional evidence of the safety and benefit of HSCT for patients with IBD due to mutations in the IL10RA gene.
Dinwiddie, Darrell L; Julia M Bracken; Julie A Bass; Kathy Christenson; Sarah E Soden; Carol J Saunders; Neil A Miller; Vivekanand Singh; David L Zwick; Charles C Roberts; Jignesh Dalal; and Stephen F Kingsmore.
"Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing.."